Skip to main content
. 2018 Jul 18;9:2801. doi: 10.1038/s41467-018-05078-8

Fig. 1.

Fig. 1

Phosphorylated EZH2 (T367) is expressed in the cytoplasm of invasive breast carcinoma and distant metastases. a Immunohistochemical analysis of pEZH2(T367) expression using a specific antibody in human tissue samples of 193 patients. Pictures show a representative invasive breast carcinoma with adjacent normal breast (left) and metastasis (right) (×400 magnification). Insets show expression of pEZH2(T367) in cancer cells (×600 magnification). b Results are tabulated. Cytoplasmic pEZH2 is significantly associated with invasive carcinoma and metastasis compared to normal and fibrocystic changes (Chi-square p < 0.00001)